Triple
T10837769
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Bruton tyrosine kinase |
E255805
|
entity |
| Predicate | isTherapeuticTargetOf |
P37016
|
FINISHED |
| Object |
zanubrutinib
Zanubrutinib is a small-molecule Bruton tyrosine kinase inhibitor used primarily in the treatment of certain B-cell malignancies such as mantle cell lymphoma and chronic lymphocytic leukemia.
|
E890926
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d6aa81a5d08190aa86689061d1ddd2 |
elicitation | completed |
| NER | batch_69d747002b3081908726901ee83d8f38 |
ner | completed |
| NED1 | batch_69dff7c739708190b0d58fc2d6392c6c |
ned_source_triple | completed |
| NED2 | batch_69e0057a7704819096becb74dc261883 |
ned_description | completed |
| NEDg | batch_69e0026e7900819087327db5f625169c |
nedg | completed |
Created at: April 8, 2026, 9:19 p.m.